SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

PMV Pharma to Present Phase 2 Rezatapopt Data at ENA 2026

PMV Pharma says Phase 2 PYNNACLE data will be featured in a late-breaking oral presentation at ENA 2026.

PMVP

Related stories